ArticleHealth science reports2026
The Rising Burden of Osteosarcopenia in Older Adults: A Narrative Review of Pathophysiology, Diagnostic Challenges, and Therapeutic Perspectives.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Osteosarcopenia, defined as the coexistence of osteoporosis and sarcopenia, is an emerging geriatric syndrome linked to the musculoskeletal decline associated with aging. It is correlated with an increased risk of falls, fractures, disability, and mortality. This review aims to synthesize the emerging concepts, underlying mechanisms, epidemiology, diagnostic challenges, and current therapeutic strategies for osteosarcopenia. Methods: A narrative review was conducted using the PubMed, Scopus, and Google Scholar databases. The keywords used were: osteosarcopenia, sarcopenia, osteoporosis, frailty, and related terms. Relevant peer-reviewed studies and reports from international organizations were included. The selected articles, addressing definitions, pathophysiology, epidemiology, diagnosis, and management, underwent thematic analysis. Results: Osteosarcopenia affects approximately 18% to 20% of older adults. Its prevalence increases with age and is higher in women. Osteosarcopenia results from mechanisms common to both bones and muscles, including chronic inflammation, hormonal decline, genetic and epigenetic factors, dysregulated signaling pathways, and the interplay between muscles and bones. Risk factors include age, sedentary lifestyle, malnutrition, chronic diseases, and endocrine disorders. Diagnosis remains complex due to the lack of standardized criteria and relies on separate assessments such as bone densitometry (DXA) for bone density and functional tests for muscle strength. The emergence of biomarkers and composite indices holds promise for improved detection. Management primarily involves resistance training, nutritional optimization (protein, calcium, vitamin D), and anti-osteoporosis medications. However, no treatment simultaneously targets both components, and pharmacological options remain limited. Conclusion: Osteosarcopenia represents a major and growing public health problem in aging populations. Despite progress in understanding its pathophysiology, gaps persist in standardized diagnosis and integrated treatment. Multidisciplinary approaches combining physical exercise, nutrition, and pharmacotherapy, as well as future research on unified diagnostic criteria and targeted therapies, are essential to reduce its impact and improve the functional abilities of older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.